The Longer Life Foundation’s mission is to fund and support the study of factors that either predict the mortality and morbidity of select populations or influence improvements in longevity, health, and wellness.

This unique foundation supports innovative independent research by scientific, medical and public health experts to make discoveries that will improve long-term mortality, enhance longevity, and promote healthier lives.

Grants by the Longer Life Foundation have supported hundreds of academicians and scientists engaged in fundamental research into longevity and health. LLF-supported research investigations produce groundbreaking results as well as substantial subsequent support by major research institutions.

RGA’s Dr. Daniel Zimmerman, Managing Director, Longer Life Foundation, spoke to Dr. Challen about why blood cancers can be so difficult to treat and what his novel research seeks to accomplish. Q: Dr. Zimmerman: To understand strategies to prevent disease, we first need to understand causes.

Investigations funded by the Longer Life Foundation have resulted in more than 175 articles to date in peer-reviewed medical journals. Find them here.

Longer Life Foundation’s investigators are some of the most innovative and creative thinkers working today in medical science.

However, using people to screen drugs for possible life-extending effects is infeasible due to ethical concerns and practical constraints due to the long lifespan of humans. Therefore, we chose a simple, short-lived animal, the nematode worm C. elegans, as a model system to screen for drugs that extend lifespan.

Washington University in St. Louis researchers: Unlock the potential of your research with our comprehensive guide to navigating the Longer Life Foundation’s funding expectations.

By understanding the mechanisms of accelerated aging and frailty, we can identify ways of intervening to mitigate the process. Accomplishing this objective will help us understand how to prevent physical frailty long-term.

organ allocation policy will have a great impact in terms of quality of life and survival. This study aimed to provide key data from the largest lung transplant program in the United States to answer the following question. Study Question: What is the association between baseline characteristics of patients with PPH evaluated for lung